 Nida Awadallah
Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Family Practice | 3 | 2021 | 403 | 1.020 |
Why?
| | Internship and Residency | 3 | 2022 | 1265 | 0.760 |
Why?
| | Education, Medical, Graduate | 3 | 2022 | 564 | 0.630 |
Why?
| | General Surgery | 1 | 2022 | 206 | 0.610 |
Why?
| | Chronic Pain | 2 | 2022 | 291 | 0.610 |
Why?
| | Mentoring | 1 | 2022 | 165 | 0.600 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2008 | 294 | 0.410 |
Why?
| | Physicians | 1 | 2020 | 952 | 0.330 |
Why?
| | Curriculum | 3 | 2022 | 1068 | 0.310 |
Why?
| | Pancreatic Neoplasms | 2 | 2008 | 928 | 0.300 |
Why?
| | B7-1 Antigen | 1 | 2008 | 55 | 0.270 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2008 | 35 | 0.270 |
Why?
| | Pain Management | 2 | 2022 | 411 | 0.240 |
Why?
| | Bile Ducts | 1 | 2006 | 67 | 0.230 |
Why?
| | Cholangitis, Sclerosing | 1 | 2006 | 61 | 0.220 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2008 | 536 | 0.200 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2006 | 222 | 0.200 |
Why?
| | Biomarkers, Tumor | 1 | 2008 | 1321 | 0.160 |
Why?
| | Ocular Hypertension | 2 | 2011 | 67 | 0.140 |
Why?
| | Delphi Technique | 1 | 2020 | 333 | 0.130 |
Why?
| | Glaucoma, Open-Angle | 2 | 2011 | 104 | 0.130 |
Why?
| | Biopsy, Fine-Needle | 2 | 2008 | 68 | 0.130 |
Why?
| | Fellowships and Scholarships | 1 | 2022 | 355 | 0.130 |
Why?
| | Pancreas | 2 | 2008 | 341 | 0.110 |
Why?
| | Community Health Services | 1 | 2016 | 231 | 0.100 |
Why?
| | Humans | 13 | 2022 | 145482 | 0.100 |
Why?
| | Clinical Competence | 1 | 2022 | 1242 | 0.100 |
Why?
| | Life Style | 1 | 2016 | 483 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1150 | 0.090 |
Why?
| | Pandemics | 1 | 2021 | 1706 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1369 | 0.090 |
Why?
| | Middle Aged | 6 | 2021 | 36169 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 6070 | 0.090 |
Why?
| | Prostaglandins F | 1 | 2011 | 15 | 0.090 |
Why?
| | Exercise Therapy | 1 | 2016 | 476 | 0.090 |
Why?
| | Family | 1 | 2016 | 687 | 0.090 |
Why?
| | Aged | 5 | 2021 | 26117 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5891 | 0.080 |
Why?
| | Primary Health Care | 2 | 2019 | 1734 | 0.070 |
Why?
| | Pediatric Obesity | 1 | 2016 | 637 | 0.070 |
Why?
| | V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2008 | 6 | 0.070 |
Why?
| | Tissue Fixation | 1 | 2008 | 36 | 0.070 |
Why?
| | Adult | 5 | 2021 | 40703 | 0.070 |
Why?
| | Immunoenzyme Techniques | 1 | 2008 | 199 | 0.070 |
Why?
| | Pilot Projects | 2 | 2016 | 1896 | 0.060 |
Why?
| | Gallstones | 1 | 2007 | 35 | 0.060 |
Why?
| | Cloprostenol | 1 | 2007 | 13 | 0.060 |
Why?
| | Timolol | 1 | 2007 | 14 | 0.060 |
Why?
| | Lithotripsy | 1 | 2007 | 53 | 0.060 |
Why?
| | Male | 6 | 2021 | 72808 | 0.060 |
Why?
| | Endosonography | 1 | 2008 | 160 | 0.060 |
Why?
| | Cholelithiasis | 1 | 2006 | 36 | 0.060 |
Why?
| | Endoscopy, Digestive System | 1 | 2007 | 141 | 0.060 |
Why?
| | Female | 6 | 2021 | 78756 | 0.060 |
Why?
| | Cholangiocarcinoma | 1 | 2006 | 108 | 0.050 |
Why?
| | Bile Duct Neoplasms | 1 | 2006 | 131 | 0.050 |
Why?
| | Neoplasm Staging | 1 | 2008 | 1468 | 0.050 |
Why?
| | United States | 1 | 2021 | 16114 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2022 | 17262 | 0.050 |
Why?
| | Antihypertensive Agents | 1 | 2007 | 518 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 2129 | 0.050 |
Why?
| | Biopsy | 1 | 2006 | 1081 | 0.050 |
Why?
| | Diagnosis, Differential | 1 | 2006 | 1507 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2008 | 3424 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2007 | 5425 | 0.040 |
Why?
| | Community-Based Participatory Research | 1 | 2019 | 167 | 0.030 |
Why?
| | Colorado | 2 | 2019 | 4572 | 0.030 |
Why?
| | Prospective Studies | 2 | 2007 | 8039 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2007 | 8320 | 0.030 |
Why?
| | Behavior Control | 1 | 2016 | 12 | 0.030 |
Why?
| | Biomarkers | 1 | 2008 | 4283 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2019 | 909 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2016 | 1119 | 0.020 |
Why?
| | Qualitative Research | 1 | 2019 | 1677 | 0.020 |
Why?
| | Blood Pressure | 1 | 2016 | 1782 | 0.020 |
Why?
| | Intraocular Pressure | 1 | 2011 | 326 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1585 | 0.020 |
Why?
| | Body Mass Index | 1 | 2016 | 2425 | 0.020 |
Why?
| | Travoprost | 1 | 2007 | 13 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2011 | 2030 | 0.020 |
Why?
| | Drug Combinations | 1 | 2007 | 397 | 0.010 |
Why?
| | Recurrence | 1 | 2007 | 1142 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2007 | 1058 | 0.010 |
Why?
| | Child | 1 | 2016 | 22680 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 11826 | 0.010 |
Why?
| | Animals | 1 | 2011 | 38141 | 0.000 |
Why?
| | Adolescent | 1 | 2007 | 22485 | 0.000 |
Why?
|
|
Awadallah's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|